What did @sp_banana_lit actually say?
The creator documents starting compounded semaglutide through Ro Pharmacy, describing a cost comparison where Ozempic runs roughly $1,000, Wegovy $695, and Ro's compounded version came in at $195 for an intro offer before settling at $400 a month. She dropped from 178 to 167 pounds after two injections and correctly hedged that early loss: "we automatically gonna lose that 10 pounds of water weight right in the beginning." She also flagged protein intake and resistance training as muscle-preservation strategies, and she's drinking close to 100 ounces of water daily. No dosing advice, no disease cure claims. This is largely an honest, unfiltered first-person account, which is refreshingly rare in the GLP-1 content space.
Does the science back this up?
More than you might expect from a TikTok. The early water weight caveat is legitimate. The muscle loss concern is also real and often underreported in GLP-1 coverage.
On rapid early weight loss: glycogen depletion in the first 1-2 weeks of significant caloric reduction does drive water loss disproportionate to fat loss. This is well-documented in basic metabolism literature and not specific to semaglutide. The creator is right to pump the brakes on that number.
On muscle loss: this is one of the more underappreciated risks of GLP-1 therapy. A 2023 analysis by Wilding et al. in Diabetes, Obesity and Metabolism noted that roughly 25-39% of weight lost on semaglutide can come from lean mass, not fat. The STEP trial data supported this direction. The creator's instinct to pair the drug with protein and resistance training is backed by evidence. Churchward-Venne et al. (2012, The American Journal of Clinical Nutrition) established that higher protein intake during energy restriction attenuates lean mass loss.
On the water intake claim, "drink at least half your body weight in water" is a popular heuristic with mixed support. General hydration recommendations from the National Academies of Sciences sit around 91-125 oz per day depending on body size, so her ~100 oz target is reasonable, but the half-bodyweight rule has no firm clinical basis.
What did they get wrong (or right)?
She got the muscle loss and protein points right. She got the early water weight caveat right. Credit where it's due.
The bigger issue is the implicit framing that Ro's compounded semaglutide is Wegovy. She says she "thought I was ordering the wagovey shot" and seems to treat compounded semaglutide as a functional equivalent. It is not. Compounded semaglutide is manufactured by a 503A or 503B pharmacy outside FDA approval. The FDA does not evaluate compounded drugs for safety, efficacy, or potency. The base compound may be semaglutide, but excipients, concentration, and sterility standards differ. The FDA issued multiple warnings in 2023 and 2024 specifically about compounded semaglutide, citing reports of adverse events linked to incorrect dosing from compounded vials versus auto-injector pens.
The $195 intro price is also worth scrutinizing. Telehealth compounding platforms frequently use low first-month pricing that escalates. Her stated $400/month ongoing cost is consistent with what several platforms charge, but patients should read the full subscription terms before assuming that price holds.
What should you actually know?
GLP-1 receptor agonists like semaglutide have genuine, robust clinical evidence behind them. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed 14.9% mean body weight reduction over 68 weeks with 2.4mg semaglutide versus 2.4% with placebo. That is real, meaningful data.
Compounded versions are a different product. The FDA placed semaglutide on the shortage list for much of 2022-2024, which legally permitted compounding pharmacies to produce it. As of early 2025, the FDA declared the shortage resolved and began taking action against compounders continuing to sell it. Patients using compounded semaglutide right now may be in a gray zone legally and face supply disruptions.
The creator's self-injection approach using a vial and separate needle is also higher-risk for dosing error than a pre-filled auto-injector. Errors in drawing from a vial can mean dramatically more or less drug than intended. Anyone using this format should get explicit guidance from a licensed prescriber on reconstitution and measurement, not TikTok.
- Muscle preservation on GLP-1s requires active effort: aim for 1.2-1.6g of protein per kg of body weight and include resistance training at least twice weekly.
- Early weight drops on semaglutide are disproportionately water and glycogen. Fat loss becomes the dominant signal after 4-8 weeks.
- Compounded semaglutide and brand-name Wegovy are not interchangeable products. Treat them differently.